EyeGate Pharmaceuticals I...

NASDAQ: EYEG · Real-Time Price · USD
35.63
-0.08 (-0.22%)
At close: Aug 18, 2025, 3:06 PM
35.65
0.05%
After-hours: Aug 18, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024
Period Ending Dec 31, 2024
Net Income
3.59M
Depreciation & Amortization
19.2K
Stock-Based Compensation
656.59K
Other Working Capital
n/a
Other Non-Cash Items
4.58M
Deferred Income Tax
-288.75K
Change in Working Capital
n/a
Operating Cash Flow
8.56M
Capital Expenditures
-6.26K
Cash Acquisitions
n/a
Purchase of Investments
-35.63M
Sales Maturities Of Investments
12.98M
Other Investing Acitivies
n/a
Investing Cash Flow
-22.66M
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
15.5M
Financial Cash Flow
15.5M
Net Cash Flow
1.34M
Free Cash Flow
8.55M